Skip to main navigation

Live - Top Menu

  • Clinical Trials
  • Investors & Media
  • Careers
  • Contact Us
Menu
Close

Main navigation

  • Our Focus
  • Our Research
  • Our Medicine
  • Our Story
Home > Investors & Media > Financial Information > SEC Filings
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

SEC Filings

SEC Filings

Filing date Form Description View
May 06, 2022 10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML
0001558370-22-007617.pdf
0001558370-22-007617.rtf
0001558370-22-007617.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
May 05, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-056142.pdf
0001104659-22-056142.rtf
0001104659-22-056142.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
May 03, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-055250.pdf
0001104659-22-055250.rtf
0001104659-22-055250.xls
May 02, 2022 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
22-13541-1_460413_print.pdf
0001104659-22-054654.rtf
0001104659-22-054654.xls
Apr 13, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-045468.pdf
0001104659-22-045468.rtf
0001104659-22-045468.xls
Mar 02, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-028993.pdf
0001104659-22-028993.rtf
0001104659-22-028993.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Mar 02, 2022 10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML
0001558370-22-002666.pdf
0001558370-22-002666.rtf
0001558370-22-002666.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 17, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-024720.pdf
0001104659-22-024720.rtf
0001104659-22-024720.xls
Feb 15, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-023838.pdf
0001104659-22-023838.rtf
0001104659-22-023838.xls
Feb 15, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-023839.pdf
0001104659-22-023839.rtf
0001104659-22-023839.xls

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

Data provided by Kaleidoscope.

  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

Live - Footer Menu

  • Privacy Policy
  • Privacy Shield Policy
  • Corporate Compliance
  • Terms of Use
  • Contact Us
  • Cookie Preferences
305 Madison Avenue|Morristown, NJ 07960|T: 844-782-ICPT
© 2022 Intercept Pharmaceuticals, Inc.